Primus Corporation

Primus Corporation is a U.S. in vitro diagnostics and medical device company focused on hemoglobin testing platforms and related assays, especially HbA1c testing for diabetes and hemoglobinopathy analysis. The company is best known for the Premier Hb9210 analyzer and related hemoglobin diagnostic products that use boronate affinity and high-performance liquid chromatography technologies. Primus was acquired by Trinity Biotech in 2005 and operates as a Trinity Biotech subsidiary/manufacturing site in Kansas City, Missouri. Its products are commercial-stage and used in clinical laboratory settings for diabetes management, abnormal hemoglobin detection, thalassemia screening, and neonatal/newborn testing. The business appears to remain active as part of Trinity Biotech's diagnostics operations.